Latest updates in hormone receptor positive HER2 negative breast cancer

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer

War in Ukraine: Global cancer aid to support refugees

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

ASCO and WHO to collaborate on quality indicators for cancer facilities

Treatment with high-dose multi-agent chemotherapy for high-risk lymphoma is effective but with significant toxicity

Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients

EHA update: Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM

Glofitamab induces durable complete remissions in patients with relapsed large B-cell lymphoma

Time-limited venetoclax-obinutuzumab +/- ibrutnib surpasses chemoimmunotherapy in frontline chronic lymphocytic leukaemia

Quizartinib advances overall survival in acute myeloid leukaemia patients

Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients